NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Samphire Neuroscience

Samphire Neuroscience

Private
LondonHealthcare & Life Scienceshttps://www.samphireneuro.com/

Last Round

Seed

Jun 3, 2025

Total Funding Raised

$7.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Samphire Neuroscience is a healthtech company that develops non-invasive, brain-stimulating wearable devices and a companion mobile application to alleviate symptoms associated with the menstrual cycle.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

neuromodulationtDCSwearable medical devicemenstrual healthfemtechnon-invasive brain stimulationneurotechdrug-free pain managementDTC medical devicehealth IoTwellness technologybiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Samphire Neuroscience Comps

Public and private peers based on sector, stage, and business model.

Samphire Neuroscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Samphire Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 3, 2025
Pre SeedFeb 21, 2024

Key People

Founding team and executive leadership

Emilė Radytė

Co-Founder, CEO

Founding Team

Ervinas Bern

CTO

Executive Team

Samphire Neuroscience Investors

Notable investors and investment history

Samphire Neuroscience investors
InvestorRounds
Ayuh VenturesSeed, Pre Seed
APEX CapitalSeed
AfterWork VenturesSeed, Pre Seed
InventureSeed
FIRSTPICKSeed, Pre Seed
CVX VenturesPre Seed
Seaside VenturesSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Added TechCrunch Media LLC. as a customer.

  • Feb 2, 2026

    Added Times Law, a legal startup, as a customer.

Samphire Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Samphire Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Samphire Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range18
Year Founded2021
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.